X. Cui

发表

First-in-human phase I study of BPI-9016M, a dual MET/Axl inhibitor, in patients with non-small cell lung cancer

Yuankai Shi, X. Hao, P. Hu, 2020, Journal of Hematology & Oncology.

Liquid chromatography-tandem mass spectrometry methods for quantification of roxadustat (FG-4592) in human plasma and urine and the applications in two clinical pharmacokinetic studies.

Xia Chen, Ji Jiang, P. Hu, 2022, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Simultaneous determination of roflumilast and its metabolite in human plasma by LC-MS/MS: Application for a pharmacokinetic study.

Ji Jiang, P. Hu, Jie Huang, 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Development of a quantitative method for four photocyanine isomers using differential ion mobility and tandem mass spectrometry and its application in a preliminary pharmacokinetics investigation.

Ji Jiang, Xin Zheng, X. Cui, 2018, Journal of chromatography. A.

Simultaneous determination of indapamide, perindopril and its active metabolite perindoprilat in human plasma using UPLC-MS/MS method.

Yaqin Wang, Xin Zheng, X. Cui, 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

A not-stop-flow online normal-/reversed-phase two-dimensional liquid chromatography-quadrupole time-of-flight mass spectrometry method for comprehensive lipid profiling of human plasma from atherosclerosis patients.

Yu Bai, Huwei Liu, Yining Huang, 2014, Journal of chromatography. A.

Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers

Yu Bai, Li Yang, Ningning Zhang, 2015, Analytical and Bioanalytical Chemistry.

Potential pharmacokinetic interactions in fixed-dose combinations of perindopril/indapamide/amlodipine compared with perindopril/indapamide and amlodipine in healthy Chinese volunteers

Yaqin Wang, Xin Zheng, Hongzhong Liu, 2023, Acta Materia Medica.

Development of a rapid and sensitive UPLC-MS/MS assay for simultaneous quantitation of Vorolanib and its metabolite in human plasma and application to a pharmacokinetics study.

Wenbo Tang, Xin Zheng, Ranran Jia, 2021, Journal of pharmaceutical and biomedical analysis.

Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib study

H Zhao, Peng Wu, W. Zhong, 2023, BMC Cancer.

Mechanistic research on the anti-hepatocellular carcinoma effect of kurarinone based on network pharmacology and experimental validation

Yanjuan Liang, Can Peng, X. Cui, 2023, European Journal of Integrative Medicine.

Simultaneous determination of a novel c-Met/AXL dual-target small-molecule inhibitor BPI-9016M and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry: Application in a pharmacokinetic study in Chinese advanced solid tumor patients.

Ji Jiang, P. Hu, Xin Zheng, 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Development of an LC-MS/MS method for quantifying ASK120067, a novel mutant-selective inhibitor of the epidermal growth factor receptor (EGFR) as well as its main metabolite in human plasma and its application in a pharmacokinetic study.

Baolan Li, Yuankai Shi, Xin Zheng, 2020, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.